Type
. Analysis of clinical data and T helper 1/T helper 2 responses in patients with different clinical forms of leprosy. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2017;50(2):208-215. Available from: http://www.scielo.br/pdf/rsbmt/v50n2/0037-8682-rsbmt-50-02-00208.pdf
Type
. A case of subcutaneous phaeohyphomycosis associated with leprosy. Infectious disorders drug targets. 2017;.
Type
. PLAU and SerpinB2 role in apoptosis in leprosy. Journal of the American Academy of Dermatology. 2017;76(6):AB199.
Type
. A 10-year retrospective analysis of leprosy cases in a hospital setup in India: Scenario in post MDT era. Journal of the American Academy of Dermatology. 2017;76(6):AB2.
Type
. Leprosy: a forgotten disease?. Medicine today. 2017;18(5):61-66.
Type
. Barriers to prevent disability due to leprosy in children are breachable. The Journal of pediatrics [Internet]. 2017;185:3. Available from: http://www.jpeds.com/article/S0022-3476(17)30499-7/pdf
Type
. Prevalence of autoantibodies against cellular antigens in patients with HIV and leprosy coinfection in the Amazon region. Infectious diseases of poverty [Internet]. 2017;6(1):80. Available from: http://tinyurl.com/yavhtrkp
Type
. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. PLoS neglected tropical diseases [Internet]. 2017;11(6):e0005506. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005506&type=printable
Type
. Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients. Cytokine. 2017;97:42-48.
Type
. Genotyping analysis of Mycobacterium leprae isolated in water environment of leprosy endemic places in Lamongan, East Java and transmission pattern of nonhuman source of infection. Journal of the American Academy of Dermatology. 2017;76(6):AB144.